Cytocom Inc. (CBLI) SEC filings
CBLI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CBLI overview →
No CBLI SEC filing events in the measured window.
Nothing matched in the current window — the CBLI overview has every event we measure for this name.
Get an email when CBLI moves on news →Keep exploring
More CBLI: earnings → · analyst actions → · CBLI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IMPRIMIS PHARMACEUTICALS (IMMY) | 435 | 0.00% | 41% |
| CATASYS (CATS) | 434 | 0.00% | 41% |
| Charles River Laboratories International, Inc. (CRL) | 434 | -0.10% | 45% |
| Nymox Pharmaceutical Corporation (NYMX) | 433 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.